Understanding Immune Causes of Kidney Membrane Disease
Treatments studied
Part of Immune system & allergy, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study examines blood and kidney tissue samples from people with membranous nephropathy—a condition where the kidney's filtering membrane is damaged by the immune system. Researchers are trying to understand which immune markers predict how the disease will progress and respond to treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have had a kidney biopsy showing membranous nephropathy, or blood tests showing specific antibodies (anti-PLA2R1 or anti-THSD7A) that indicate this condition
- You are able to understand the study and provide written consent to participate
- Your kidney biopsy and blood test results are clearly diagnostic (not uncertain or incorrect)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at immune “B cells” in people with membranous nephropathy (a kidney disease). It includes people who have received or are being considered for B-cell–depleting treatment, aiming to better understand what drives the disease and how it may respond.
This study looks at how primary membranous nephropathy (a kidney disease where the kidney's filters become inflamed and leak protein) progresses over time. It aims to develop a tool to help predict which patients might get worse, so doctors can personalize care.
This trial studies biological samples from patients with membranous nephropathy to understand why rituximab treatment sometimes stops working. It may help doctors find better ways to treat this kidney condition.
This study looks at substances in the blood of people with nephrotic syndrome, a condition that causes protein to leak into the urine. It may help doctors understand the disease better.
This trial looks at how people with primary membranous nephropathy (a kidney disease that causes swelling and protein in urine) do over time with their current treatment. It helps doctors understand which treatments work best, especially for those with severe protein loss.
This study is for children (and some newly diagnosed patients) who have nephrotic syndrome—kidneys leaking a lot of protein. It aims to better understand the kidney condition (sometimes using biopsy) and support future care decisions.
Hear when a new Membranous Nephropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.